How does leuprolide interact with angiogenic factors during follicular development, and what are the implications for ovarian stimulation protocols?
Gaurav ChauhanContributor
How does leuprolide interact with angiogenic factors during follicular development?
Share
Leuprolide, a GnRH agonist, downregulates LH and FSH levels, reducing angiogenic factors like VEGF in the ovary. This affects follicular angiogenesis, potentially leading to altered ovarian response in stimulation protocols.